IMG Wealth Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.27K Buy
61
+36
+144% +$1.86K ﹤0.01% 417
2026
Q1
$1.27K Buy
25
+12
+92% +$560 ﹤0.01% 463
2025
Q4
$383 Hold
13
﹤0.01% 576
2025
Q3
$336 Hold
13
﹤0.01% 543
2025
Q2
$359 Hold
13
﹤0.01% 475
2025
Q1
$369 Hold
13
﹤0.01% 286
2024
Q4
$541 Buy
+13
New +$621 ﹤0.01% 247

Other funds holding MRNA

IMG Wealth Management's MRNA Position: Q2 2026 in Review

IMG Wealth Management increased its Moderna (MRNA) stake by 144% in Q2 2026, buying an estimated $1.86K and bringing the position to 61 shares worth $4.27K. The position accounts for ﹤0.01% of the portfolio, ranked #417.

IMG Wealth Management first reported a position in MRNA in Q4 2024 and has held it in 7 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • IMG Wealth Management held 61 shares of Moderna worth $4.27K as of Q2 2026.
  • IMG Wealth Management bought 36 Moderna shares in Q2 2026, an estimated $1.86K.
  • Moderna made up ﹤0.01% of IMG Wealth Management's portfolio in Q2 2026, its #417 holding.
  • IMG Wealth Management first reported a position in Moderna in Q4 2024 and has held it in 7 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on IMG Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.